Back to search

Clemson University

In Vitro Studies of Heparin-Coated Magnetic Nanoparticles for Potential Use in the Treatment of Neointimal Hyperplasia

Abstract

dc:description.abstract

With the ever-increasing prevalence of atherosclerosis, procedures such as angioplasty and stenting have become common practice, both of which are simple techniques spouting relatively satisfying results for the past several decades. While successful in opening of occluded vessels, these therapies can be met down the line with thrombosis or even repeated occlusion of the vessel, known as restenosis. Similar to the issues faced within oncology, treatment of this restenosis via widespread drug administration throughout the body is not desirable. Cardiovascular and other medical fields have begun looking into the use of magnetic nanoparticles as a drug delivery vessel. Previously, our lab proposed the use of these particles to concentrate and carry drug doses for local delivery as treatment of neointimal hyperplasia leading to restenosis. This pairing would allow concentrated drug doses to be carried directly to the affected vessel position, without adverse effects elsewhere in the vessel or even the entire body.

Degree

thesis:*
Name thesis:degree_name
Master of Science (MS)
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Bioengineering

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hargett, Andrew
Contributors dc:contributor
  • Dr. Delphine Dean, Committee Chair
  • Dr. Martine LaBerge
  • Dr. O. Thompson Mefford

Subjects

dc:subject × 6

Identifiers

dc:identifier.*
Repository record dc:identifier
https://open.clemson.edu/all_theses/2365

Chain of custody

source
Harvested from
Clemson University
Base URL
open.clemson.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Hargett, Andrew. In Vitro Studies of Heparin-Coated Magnetic Nanoparticles for Potential Use in the Treatment of Neointimal Hyperplasia. Thesis thesis, https://open.clemson.edu/all_theses/2365